Deltex (DEMG) reported FY16 group revenues of £6.3m, marginally lower than the £6.4m total in FY15 however, with sustained momentum from US probe sales, up 40% to £1.9m in FY16, offsetting UK weakness. Gross margin improvement up to 68% from 63% was driven by the higher proportion of US sales and by manufacturing efficiencies. Looking ahead, the improving picture is based on sharper focus on the highest contributing US accounts, potential stabilisation of UK revenues and with further margin improvements in view.
04 May 2017
An improving picture, a sharper focus
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
An improving picture, a sharper focus
Deltex Medical Group plc (DEMG:LON) | 0.1 0 0.0% | Mkt Cap: 2.37m
- Published:
04 May 2017 -
Author:
Emma Ulker -
Pages:
6
Deltex (DEMG) reported FY16 group revenues of £6.3m, marginally lower than the £6.4m total in FY15 however, with sustained momentum from US probe sales, up 40% to £1.9m in FY16, offsetting UK weakness. Gross margin improvement up to 68% from 63% was driven by the higher proportion of US sales and by manufacturing efficiencies. Looking ahead, the improving picture is based on sharper focus on the highest contributing US accounts, potential stabilisation of UK revenues and with further margin improvements in view.